BioMarin Pharmaceutical reported $1.44 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 0.86 0.91 Oct/22 2025
FY2025Q2 Jun/2025 1.44 0.84 0.96 Aug/04 2025
FY2025Q1 Mar/2025 1.13 0.65 0.71 May/01 2025
FY2024Q4 Dec/2024 0.92 0.55 0.49 Feb/19 2025
FY2024Q3 Sep/2024 0.91 0.53 0.46 Oct/29 2024
FY2024Q2 Jun/2024 0.96 0.35 0.29 Aug/05 2024
FY2024Q1 Mar/2024 0.71 0.32 0.27 Apr/24 2024
FY2023Q4 Dec/2023 0.49 0.20 0 Feb/22 2024
FY2023Q3 Sep/2023 0.46 0.23 -0.04 Nov/01 2023
FY2023Q2 Jun/2023 0.29 0.23 0.15 Jul/31 2023
FY2023Q1 Mar/2023 0.27 0.21 0.18 Apr/26 2023
FY2022Q4 Dec/2022 -0.07 -0.32 Feb/27 2023


Eps Change Date
Acadia Pharmaceuticals USD 0.16 0.05 Jun/2025
Agios Pharmaceuticals USD -1.93 0.38 Jun/2025
Alnylam Pharmaceuticals USD 0.32 0.33 Jun/2025
Amgen USD 6.02 1.12 Jun/2025
Bayer EUR 1.23 1.26 Jun/2025
Biogen USD 5.47 2.45 Jun/2025
BioMarin Pharmaceutical USD 1.44 0.31 Jun/2025
Gilead Sciences USD 2.01 0.2 Jun/2025
Incyte USD 1.57 0.41 Jun/2025
Insmed USD -1.7 0.28 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
Moderna USD -2.13 0.39 Jun/2025
Neurocrine Biosciences USD 1.65 0.95 Jun/2025
PTC Therapeutics USD -0.83 10.87 Jun/2025
Regeneron Pharmaceuticals USD 12.89 4.67 Jun/2025
Roche Holding CHF 8.57 1.66 Dec/2024
Sanofi USD 1.66 0.9 Jun/2025
Sarepta Therapeutics USD 2.02 5.44 Jun/2025
Ultragenyx Pharmaceutical USD -1.17 0.4 Jun/2025
United Therapeutics USD 6.41 0.22 Jun/2025
Vertex Pharmaceuticals USD 4.52 0.46 Jun/2025